VLGEA

Zacks analysts reviewed five stocks on October 14, 2026. Walmart maintains strong fundamentals with solid omnichannel growth but faces margin pressures.

Visa leads digital payments with momentum but elevated valuations and rising costs concern analysts. Novo Nordisk's semaglutide drugs drive growth despite competitive pressures and underperformance.

Village Super Market outperforms its industry with steady growth and operational flexibility. Empire Petroleum struggles with liquidity constraints and declining production despite long-term growth potential.

Village Super Market (VLGEA) reported fourth-quarter fiscal 2026 earnings of 92 cents per share, down 12.4% year-over-year, despite revenues rising 1.7% to $609.6 million. Net income declined 12.3% to $13.6 million.

While same-store sales grew 1.6% and digital sales increased 6%, the company faced headwinds from rising operating costs, higher employee expenses, and egg price deflation. Full-year fiscal 2026 net income fell to $52.5 million from $56.4 million despite 3.7% sales growth.

Zacks Research Daily features analysis of 16 major stocks and 2 microcap companies. Walmart maintains strong fundamentals with omnichannel growth but faces margin pressures.

Visa leads digital payments but experiences rising client incentives weighing on profitability. Novo Nordisk's semaglutide drugs drive growth despite competitive pressures. Additional coverage includes Shopify, Union Pacific, Monster Beverage, and others with mixed outlooks.